Skip to content

Thomas James Lynch

Massachusetts General Hospital

3 papers in the Anchorcite directory, published between 2004 and 2010, cited 23,730 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Daniel A. Haber · 2 papers
  • Daphne W. Bell · 1 paper
  • Raffaella Sordella · 1 paper
  • Sarada Gurubhagavatula · 1 paper
  • Ross A. Okimoto · 1 paper
  • Brian W. Brannigan · 1 paper
  • Patricia L. Harris · 1 paper
  • Sara M. Haserlat · 1 paper

Papers

  1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine · 2004 · 11,565 citations

    BACKGROUND: Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR). However, about 10 percent of patients have a rapid and often dramatic clinical response. The molecular…

  2. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine · 2010 · 7,685 citations

    BACKGROUND: Patients with metastatic non-small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the effect of introducing palliative care early after diagnosis on patient-reported outcomes and end-of-life care among…

  3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine · 2010 · 4,480 citations

    BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors. We explored the therapeutic efficacy of inhibiting ALK in such tumors in…

Metadata from OpenAlex (CC0).